MARKET

RHHBF

RHHBF

Roche Hldgs Ag
OTCQX
486.00
+16.00
+3.40%
Closed 13:16 02/17 EST
OPEN
486.00
PREV CLOSE
470.00
HIGH
486.00
LOW
486.00
VOLUME
40
TURNOVER
19.44K
52 WEEK HIGH
486.00
52 WEEK LOW
296.00
MARKET CAP
--
P/E (TTM)
24.04
1D
5D
1M
3M
1Y
5Y
1D
Reported Monday, Roche Advances Immunology Leadership As Gazyva Phase III MAJESTY Study Shows Clinically Meaningful Remission Results In Primary Membranous Nephropathy
Benzinga · 18h ago
Roche commits to net zero emissions by 2045
Reuters · 20h ago
Roche Appoints Mark Dawson as Head of Pharma Research and Early Development
Reuters · 20h ago
Weekly Report: what happened at RHHBF last week (0209-0213)?
Weekly Report · 1d ago
Roche Reports Positive Phase III Results for Gazyva in Primary Membranous Nephropathy
Reuters · 1d ago
ROCHE HOLDING AG - MAJESTY, FIRST GLOBAL PHASE III STUDY IN PRIMARY MEMBRANOUS NEPHROPATHY, MET ITS PRIMARY ENDPOINT OF COMPLETE REMISSION AT TWO YEARS
Reuters · 1d ago
Viking Therapeutics posts FY 2025 research and development expenses of USD 345.0 million
Reuters · 6d ago
Bristol-Myers: Walking Blindfolded To A $30 Billion Patent Cliff
Seeking Alpha · 6d ago
More
About RHHBF
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Webull offers Roche Holding AG stock information, including OTCQX: RHHBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RHHBF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RHHBF stock methods without spending real money on the virtual paper trading platform.